Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion

Exclusion Criteria

• •1. Subjects was allergic to paclitaxel.
• •2. Subjects with contraindications or hypersensitivity to antiplatelet therapy.
• •3. Subject had life expectancy of less than 2 years.
• •4. Those who have undergone vascular surgery on the target lesion within the past 6 weeks.
• •5. Those who have in-stent restenosis (ISR) on the target lesion.
• •6. Those who have non-arteriosclerotic vascular disease, such as an aneurysm or vasculitis, on the target lesion.
• •7. Women who were pregnant, breast-feeding or intended to become pregnant.
• •8. Those who cannot perform pre-dilatation or who fail to apply the device, making it difficult to apply the device.
• •9. Those who have a Grade D or higher vascular dissection restricting blood flow after pre-dilatation or who require stent placement.
• •10. Those who, in the investigator's judgment, are not suitable for this study or may increase the risks associated with participation in the study.